Amplifold GmbH is a Munich-based LMU spin-off developing an ultrasensitive signal amplification platform for lateral flow immunoassays (LFAs). Using DNA-origami nanostructures as programmable adapters, Amplifold enables up to ~100-fold sensitivity improvements while preserving simplicity, robustness and low cost of strip-based tests. With the vision “Affordability meets Accuracy” and “nanoscale design. Global diagnostic impact”, Amplifold aims to become the technology leader for ultrasensitive LFAs in in vitro diagnostics and life sciences.
